145 related articles for article (PubMed ID: 17272306)
1. BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells.
Thériault BL; Shepherd TG; Mujoomdar ML; Nachtigal MW
Carcinogenesis; 2007 Jun; 28(6):1153-62. PubMed ID: 17272306
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
Bagnato A; Rosanò L
Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812
[TBL] [Abstract][Full Text] [Related]
3. Bone morphogenetic protein 4 induces epithelial-mesenchymal transition through MSX2 induction on pancreatic cancer cell line.
Hamada S; Satoh K; Hirota M; Kimura K; Kanno A; Masamune A; Shimosegawa T
J Cell Physiol; 2007 Dec; 213(3):768-74. PubMed ID: 17516553
[TBL] [Abstract][Full Text] [Related]
4. Autocrine BMP4 signalling regulates ID3 proto-oncogene expression in human ovarian cancer cells.
Shepherd TG; Thériault BL; Nachtigal MW
Gene; 2008 May; 414(1-2):95-105. PubMed ID: 18372118
[TBL] [Abstract][Full Text] [Related]
5. BMP4 induces an epithelial-mesenchymal transition-like response in adult airway epithelial cells.
Molloy EL; Adams A; Moore JB; Masterson JC; Madrigal-Estebas L; Mahon BP; O'Dea S
Growth Factors; 2008 Feb; 26(1):12-22. PubMed ID: 18365875
[TBL] [Abstract][Full Text] [Related]
6. Endothelin-1 is required during epithelial to mesenchymal transition in ovarian cancer progression.
Rosanò L; Spinella F; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A
Exp Biol Med (Maywood); 2006 Jun; 231(6):1128-31. PubMed ID: 16741062
[TBL] [Abstract][Full Text] [Related]
7. Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells.
Kajiyama H; Shibata K; Terauchi M; Yamashita M; Ino K; Nawa A; Kikkawa F
Int J Oncol; 2007 Aug; 31(2):277-83. PubMed ID: 17611683
[TBL] [Abstract][Full Text] [Related]
8. Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression.
Gordon KJ; Dong M; Chislock EM; Fields TA; Blobe GC
Carcinogenesis; 2008 Feb; 29(2):252-62. PubMed ID: 17999987
[TBL] [Abstract][Full Text] [Related]
9. Characterization of LMX-1A as a metastasis suppressor in cervical cancer.
Liu CY; Chao TK; Su PH; Lee HY; Shih YL; Su HY; Chu TY; Yu MH; Lin YW; Lai HC
J Pathol; 2009 Oct; 219(2):222-31. PubMed ID: 19644956
[TBL] [Abstract][Full Text] [Related]
10. Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer.
Li HZ; Wang Y; Gao Y; Shao J; Zhao XL; Deng WM; Liu YX; Yang J; Yao Z
Mol Cancer Res; 2008 Jun; 6(6):917-28. PubMed ID: 18567796
[TBL] [Abstract][Full Text] [Related]
11. TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling.
Cicchini C; Laudadio I; Citarella F; Corazzari M; Steindler C; Conigliaro A; Fantoni A; Amicone L; Tripodi M
Exp Cell Res; 2008 Jan; 314(1):143-52. PubMed ID: 17949712
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm.
Ahmed N; Thompson EW; Quinn MA
J Cell Physiol; 2007 Dec; 213(3):581-8. PubMed ID: 17708542
[TBL] [Abstract][Full Text] [Related]
13. Rho activation is required for transforming growth factor-beta-induced epithelial-mesenchymal transition in lens epithelial cells.
Cho HJ; Yoo J
Cell Biol Int; 2007 Oct; 31(10):1225-30. PubMed ID: 17537651
[TBL] [Abstract][Full Text] [Related]
14. Identification of a putative autocrine bone morphogenetic protein-signaling pathway in human ovarian surface epithelium and ovarian cancer cells.
Shepherd TG; Nachtigal MW
Endocrinology; 2003 Aug; 144(8):3306-14. PubMed ID: 12865307
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB in human endometriotic epithelial cells.
Grund EM; Kagan D; Tran CA; Zeitvogel A; Starzinski-Powitz A; Nataraja S; Palmer SS
Mol Pharmacol; 2008 May; 73(5):1394-404. PubMed ID: 18252806
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of bone morphogenetic protein binding sites and Smad1/5 activation in human vascular cells.
Upton PD; Long L; Trembath RC; Morrell NW
Mol Pharmacol; 2008 Feb; 73(2):539-52. PubMed ID: 17989347
[TBL] [Abstract][Full Text] [Related]
17. Involvement of RHO GTPases and ERK in synuclein-gamma enhanced cancer cell motility.
Pan ZZ; Bruening W; Godwin AK
Int J Oncol; 2006 Nov; 29(5):1201-5. PubMed ID: 17016652
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic proteins enhance an epithelial-mesenchymal transition in normal airway epithelial cells during restitution of a disrupted epithelium.
McCormack N; Molloy EL; O'Dea S
Respir Res; 2013 Mar; 14(1):36. PubMed ID: 23509993
[TBL] [Abstract][Full Text] [Related]
19. A cross-link between protein kinase A and Rho-family GTPases signaling mediates cell-cell adhesion and actin cytoskeleton organization in epithelial cancer cells.
Leve F; de Souza W; Morgado-Díaz JA
J Pharmacol Exp Ther; 2008 Dec; 327(3):777-88. PubMed ID: 18791066
[TBL] [Abstract][Full Text] [Related]
20. Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists.
Ye L; Lewis-Russell JM; Kynaston H; Jiang WG
J Urol; 2007 Sep; 178(3 Pt 1):1086-91. PubMed ID: 17644136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
